By Finance Pulse in Transformative —

BioNTech Settles Vaccine Royalty Disputes with NIH and UPenn

BioNTech reaches settlements with NIH and University of Pennsylvania over COVID-19 vaccine royalties, marking a significant legal resolution in healthcare.

An artistic depiction of BioNTech's logo intertwined with medical symbols, set against a backdrop of
BioNTech Settles Vaccine Royalty Disputes with NIH and UPenn

BioNTech has entered into settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over COVID-19 vaccine royalties.

Source